Latest videos


At the American Academy of Neurology (AAN) Annual Meeting in Vancouver, Canada, we talked with Steven Sparagana, MD of the Texas Scottish Rite Hospital for Children about subependymal giant cell astrocytoma (SEGA) treatment patterns among patients with tuberous sclerosis complex (TSC). SEGAs are benign brain lesions that occur in 10% to 20% of TSC patients.
Reference
Krueger D, Song J, Swallow E, et al. Subependymal Giant Cell Astrocytoma Treatment Patterns among Patients with Tuberous Sclerosis Complex. Poster presented at: 68th Annual Meeting of the American Academy of Neurology; April 15-21, 2016; Vancouver, BC.
To read the abstract, go to http://www.abstractsonline.com..../pp8/#!/4046/present


Clare Stuart, Project Manager with The Australasian Tuberous Sclerosis Society, gives a presentation to families affected by Tuberous Sclerosis Complex (TSC).
Recorded at the 2013 Family Conference of the Australasian Tuberous Sclerosis Society. Find out more at www.atss.org.au


At the 2013 DIA NORD Conference on Rare Diseases & Orphan Drugs, we had the privilege of talking to Kari Luther Rosbeck, President and CEO of The Tuberous Sclerosis Alliance. In this interview, Kari talks about the origins of the Alliance.
Tuberous sclerosis complex (TSC) is a genetic disorder that causes non-malignant tumors to form in many different organs, primarily in the brain, eyes, heart, kidney, skin and lungs. Symptoms vary but the ones most commonly associated TSC are the central ones including, seizures, developmental delay, intellectual disability and autism. At present there is no cure for TSC however Afinitor (everolimus) is approved to treat
1) patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection
2) Treatment of adults with renal angiomyolipoma and tuberous sclerosis complex (TSC) not requiring immediate surgery.
For more information about the Alliance, visit www.tsalliance.org


TS Alliance President & CEO Kari Luther Rosbeck addresses questions about the organization as well as tuberous sclerosis complex (TSC), a rare genetic disease that causes tumors to form in vital organs. TSC is also a leading genetic cause of both epilepsy and autism. Video compliments of www.givinglibrary.org.